Skip to main content

Day: July 20, 2021

Alstom SA: Alstom’s orders and sales for the first three months of 2021/22

Alstom’s orders and sales for the first three months of 2021/22Exceptional order intake of €6.4 billion for Q1 2021/22 including several large orders Solid three months of sales at €3.7 billion Sustained backlog at €76.8 billion20 July 2021 – Over the first quarter of 2021/22 (from 1 April to 30 June 2021), Alstom booked its first fully combined quarterly result with €6.4 billion of orders. The Group’s sales reached €3.7 billion. The book-to-bill ratio was very high at 1.74. The backlog, as of 30 June 2021, reached €76.8 billion, providing strong visibility on future sales. Key figuresActual figures(in € million) 2020/21Q1   2020/21Q1 proforma    2021/22Q1 % ChangeReported % ChangeproformaOrders received 1,651 3,058 6,439 +290% +106%  Sales 1,507...

Continue reading

Form 8.5 (EPT/RI) – Sumo Group plc

FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY   1.        KEY INFORMATION  (a)        Name of exempt principal trader:Investec Bank plc(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeSumo Group plc(c)        Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Broker to Sumo Group plcd)        Date dealing undertaken:19th July 2021(e)        Has the EPT previously disclosed, or is it today disclosing, in respect of any other party to this offer? No  2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER   (a)        Purchases and sales  Class of relevant...

Continue reading

DNA Plc Half-Year Financial Report 2021: EBITDA, operating result and total revenues increased – mobile data usage per subscription rises to almost 40 gigabytes per month

DNA PLC STOCK EXCHANGE RELEASE 20 JULY 2021, 8:30 AM EEST This is a summary DNA’s Half-Year Financial Report 2021. The complete report is attached to this release and is also available at www.dna.fi/investors. Due to delisting of DNA’s share from Nasdaq Helsinki on 3 February 2020, DNA is not subject to reporting obligations as an issuer of shares as set out in the Finnish Securities Markets Act. DNA is still subject to reporting obligations as an issuer of senior unsecured fixed rate notes due 2025 (ISIN: FI4000312095) listed in Nasdaq Helsinki stock exchange. Summary Unless otherwise stated, the comparison figures in brackets refer to the corresponding period in the previous year (reference period). Figures are unaudited. January-June 2021Total revenues grew 4% and amounted to EUR 476 million (457). Mobile revenues grew 2% and amounted...

Continue reading

QCT Joins Forces with DZS to Create Blueprints for 5G Network Service Deployment

Companies sign Global Partnership Teaming Agreement to deepen collaboration in network virtualization, edge cloud and Open RAN PLANO, Texas, July 19, 2021 (GLOBE NEWSWIRE) — Quanta Cloud Technology (QCT), a global data center solution provider, and DZS (NASDAQ: DZSI), a global leader in optical and packet-based mobile transport, broadband connectivity, and software defined networking solutions, today announced a strategic partnership to jointly accelerate virtualization and containerized Open RAN-based infrastructures for telco operators. This partnership between DZS and QCT leverages DZS mobile transport, telco edge, and converged network expertise and QCT’s server and NFV infrastructure integration capabilities, to address carrier and operator business opportunities in 5G, edge cloud and network virtualization. “The collaboration...

Continue reading

Back to growth

(Fornebu, 20 July 2021) «Telenor returned to growth in the second quarter. The growth was driven by strong performance in the Nordics combined with a growing subscriber base and increased data consumption in the Asian markets. Subscription and traffic revenues increased by 2%. Combined with progress on the modernisation agenda this resulted in an EBITDA uplift of 4%. In Norway, the decline in fixed legacy revenues are offset by growth in fibre and fixed wireless accesses and mobile service revenues. Improved subscription development in Sweden contributed positively towards stabilisation of the subscription and traffic revenues. Furthermore, Finland and Denmark continued its strong performance, delivering both revenue and EBITDA growth in the quarter. In Asia, Telenor aims to strengthen the position in our markets and be better positioned...

Continue reading

Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19

Full approval is based on a global phase III trial which found casirivimab and imdevimab reduced hospitalisation or death by 70% in high-risk non-hospitalised patientsBasel, 20 July 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve™(casirivimab and imdevimab), for the treatment of patients with mild to moderate COVID-19 via intravenous infusion. The antibody combination was granted a Special Approval Pathway under article 14-3 of the Pharmaceuticals and Medical Devices Act. “Ronapreve has been shown to improve survival in high-risk, non-hospitalised COVID-19 patients by reducing the risk of hospitalisation and death. In addition, its ability to retain activity against emerging variants, including the Delta variant, has been demonstrated in...

Continue reading

LHV Group unaudited results for Q2 2021

In the second quarter of 2021, AS LHV Group altogether earned EUR 12.9 million in consolidated net profit. Within the quarter, the bank earned EUR 16.5 million in net profit, including EUR 3.1 million from servicing clients related to the United Kingdom branch. Varahaldus generated EUR 2.3 million in net loss, and Kindlustus generated EUR 112,000 in net loss. The return on equity (ROE) of the Group was 19.7% in the second quarter. Compared to the first quarter of this year, the Group’s net profit was EUR 1.5 million higher, i.e., 13% higher. Compared to the second quarter of 2020, net profit increased by 3.6 times, growing by EUR 9.4 million. At the end of Q2, the volume of assets of LHV Group was EUR 5.86 billion. Within the quarter, the Group’s consolidated loan portfolio grew by EUR 97 million to EUR 2.4 billion (+4%; + EUR 96 million...

Continue reading

Fortuna reports production of 55,953 gold equivalent ounces for the second quarter and issues updated guidance for 2021

VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports production results for the second quarter from its three operating mines in the Americas, the San Jose Mine in Mexico, the Caylloma Mine in Peru, and the Lindero Mine in Argentina. The company produced 1,892,822 ounces of silver and 31,048 ounces of gold or 55,953 gold equivalent1 ounces. Silver and gold production for the first six months of 2021 totaled 3,806,577 ounces and 65,603 ounces, respectively, or 115,690 gold equivalent1 ounces. The company is also providing an updated production and cost guidance for 2021 which also incorporates gold production for the second half of the year from the Yaramoko Mine in Burkina Faso. Second Quarter Consolidated ProductionSilver production of 1,892,822 ounces; 49 percent...

Continue reading

Give and Go Prepared Foods (U.S.A.) Corp. Conducts Voluntary Recall of Certain Muffin Products Due to Possible Health Risk

SHIRLEY, N.Y., July 19, 2021 (GLOBE NEWSWIRE) — Give and Go Prepared Foods (U.S.A.) Corp. announced today a voluntary nationwide recall of certain muffin products due to the potential for the products to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women. This recall is limited solely to the products listed below, which have been sold in retail stores nationwide. No other Give & Go products are affected, and this recall does not affect products in countries...

Continue reading

AgraFlora Announces Debt Settlement

VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) announces that its Board of Directors has approved the settlement of amounts owing for services rendered (the “Debt Settlement“) through the issuance of common shares (the “Shares”). Pursuant to the Debt Settlement, the Company issued an aggregate amount of 803,783 Shares at a deemed price of $0.05 per Share. All Shares issued will be subject to a minimum hold period of four months and one day from the date of issuance. About AgraFlora Organics International Inc. AgraFlora Organics International Inc. is a cannabis company building shareholder value through the development of revenue-generating, operated assets in the global cannabis industry....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.